NovaBay Pharmaceuticals Stock (AMEX: NBY) stock price, news, charts, stock research, profile.
Open | $0.87 |
Close | $0.74 |
Volume / Avg. | 145.59M / 272.34K |
Day Range | $0.62 - $1.01 |
52 Wk Range | 0.36 - 17.74 |
Market Cap | $3.47M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 62 |
Short Interest | 2.78% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NovaBay Pharmaceuticals (AMEX:NBY) through any online brokerage.
Other companies in NovaBay Pharmaceuticals’s space includes: Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
NovaBay Pharmaceuticals has a consensus price target of $3.90.
The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $0.71 last updated September 20, 2024 at 7:59 PM EDT.
There are no upcoming dividends for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.